2026-01-02 - Analysis Report
Okay, here's a comprehensive analysis of Salesforce (CRM) based on the provided data.

**1. Return Rate Comparison:**

*   **Company Overview:** Salesforce Inc. is a leading cloud-based software company providing customer relationship management (CRM) services.
*   **CRM Cumulative Return:** -6.74%
*   **S&P 500 (VOO) Cumulative Return:** 105.07%
*   **Divergence:**  -111.8 (Relative Divergence: 8.0)

**Analysis:**  Salesforce has significantly underperformed the S&P 500 over the analyzed period.  The divergence of -111.8 indicates substantial underperformance. The relative divergence of 8.0 suggests that the current divergence is near the lower end of its historical range compared to the S&P 500.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD    | Alpha | Beta | Cap(B) |
|------------|---------|--------|-------|------|--------|
| 2016-2018  | 101.0%  | 73.2%  | 72.0% | 1.4  | 130.4  |
| 2017-2019  | 106.0%  | 73.2%  | 64.0% | 1.4  | 154.8  |
| 2018-2020  | 95.0%   | 76.4%  | 63.0% | 1.1  | 211.8  |
| 2019-2021  | 67.0%   | 76.4%  | -9.0% | 1.1  | 241.9  |
| 2020-2022  | -27.0%  | 80.0%  | -46.0% | 1.2  | 126.2  |
| 2021-2023  | 17.0%   | 87.2%  | -12.0% | 1.4  | 250.5  |
| 2022-2024  | 44.0%   | 85.3%  | 13.0% | 1.4  | 318.3  |
| 2023-2025  | 58.0%   | 76.7%  | -10.0% | 1.2  | 252.2  |

**Analysis:**
* **CAGR:**  Historical compound annual growth rates (CAGR) have fluctuated significantly, with strong performance earlier in the period and more recent volatility.
* **MDD:** The Maximum Drawdown (MDD) is consistently high, indicating substantial risk and price volatility.
* **Alpha:** Alpha, a measure of outperformance relative to the market, has been negative in several recent periods, reinforcing the underperformance noted above.
* **Beta:** Beta consistently hovers around 1.1-1.4, indicating higher volatility than the market.
* **Capitalization:** Market capitalization has generally increased over time, despite performance fluctuations.

**2. Recent Stock Price Fluctuations:**

*   **Current Close:** 264.91
*   **Last Market Data:** Price: 264.91, Previous Close: 265.92, Change: -0.38
*   **5-day SMA:** 265.68
*   **20-day SMA:** 259.90
*   **60-day SMA:** 249.06

**Analysis:** The stock price is currently slightly below its 5-day SMA, but above both its 20-day and 60-day SMAs. This suggests a potential short-term pullback within a longer-term upward trend. The negative change from the previous close (-0.38) indicates a slight recent dip.

**3. Technical Indicators:**

*   **Market Risk Indicator (MRI):** 0.9 (Medium Investment Recommended)
*   **RSI:** 51.39
*   **PPO:** 0.11
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (1 shares - Safe - MRI:0.80)
*   **Recent (20 days) relative divergence change:** 1.4 (+): 단기상승 (Short-term increase)
*   **Expected Return (%):** 0.0  (No expected excess return compared to S&P 500)

**Analysis:**
*   **MRI:** The MRI suggests a medium investment recommendation, implying moderate risk.
*   **RSI:** An RSI of 51.39 is neutral, indicating neither overbought nor oversold conditions.
*   **PPO:**  A PPO of 0.11 is close to 0, suggesting no strong positive or negative momentum.
*   **Hybrid Signal:** The hybrid signal recommends buying a portion of the stock with the limited cash suggesting a conservative approach.
*   **Relative Divergence Change:**  The positive change in relative divergence suggests a recent improvement in CRM's performance compared to the S&P 500, although from a low base.
*   **Expected Return:** The zero expected return is a significant concern, suggesting no anticipated outperformance of the S&P 500.

**4. Recent News & Significant Events:**

*   **Positive Sentiment:**
    *   "Salesforce Earnings Might Have Been Good Enough to End Its Stock’s 3 Quarter Losing Streak"
    *   "Salesforce Stock Now 27% Cheaper, Time To Buy"
    *   "Salesforce: Top Pick For 2026, The Death Of SaaS Has Been Overstated"
*   **Partnership & Growth:**
    *   "Salesforce, Inc. (CRM) Expands Partnership With USDOT"
*   **Price Prediction:**
    *   "Salesforce Inc. (NYSE: CRM) Price Prediction and Forecast 2026-2030 (January 2026)"
*   **Watchlist:**
    *   "Salesforce (CRM) Stock Today: Weekend Headlines, Analyst Price Targets, and What to Watch Before Monday’s Market Open"

**Analysis:**  Recent news articles present a mixed picture. While there's positive sentiment around potential recovery, bargain opportunities, and long-term potential, there are also articles simply highlighting analyst expectations. The partnership news is a positive indicator of continued growth and market relevance.

**4-2. Analyst Opinions:**

*   **Consensus:** Buy (Mean: 1.64)
*   **Opinions:** 53
*   **Target Price (avg/high/low):** 330.06 / 475.00 / 223.00

**Analysis:** Analyst consensus is generally positive ("Buy") with a significant upside potential based on the average target price of $330.06. However, the wide range between the high and low target prices indicates uncertainty.

**5. Recent Earnings Analysis:**

| 날짜       | EPS  | 매출    |
|------------|------|---------|
| 2025-12-04 | 2.2  | 10.26 B$ |
| 2025-09-04 | 1.97 | 10.24 B$ |
| 2025-05-29 | 1.61 | 9.83 B$ |
| 2024-12-04 | 1.6  | 9.44 B$ |
| 2025-12-04 | 1.6  | 9.44 B$ |

**Analysis:** Both EPS and Revenue have shown consistent growth over the last few quarters. This is a positive sign for the company's financial health and future prospects.

**6. Financial Information:**

**Revenue and Profitability:**

| Quarter      | Revenue  | Profit Margin |
|--------------|----------|---------------|
| 2025-10-31   | $10.26B  | 78.02%        |
| 2025-07-31   | $10.24B  | 78.10%        |
| 2025-04-30   | $9.83B   | 76.96%        |
| 2025-01-31   | $9.99B   | 77.81%        |
| 2024-10-31   | $9.44B   | 77.71%        |

**Capital and Profitability:**

| Quarter      | Equity   | ROE   |
|--------------|----------|-------|
| 2025-10-31   | $60.02B  | 3.48% |
| 2025-07-31   | $61.33B  | 3.08% |
| 2025-04-30   | $60.67B  | 2.54% |
| 2025-01-31   | $61.17B  | 2.79% |
| 2024-10-31   | $58.52B  | 2.61% |

**Analysis:**

*   **Revenue and Profitability:** Revenue is steadily increasing, and profit margins are consistently high, demonstrating strong operational efficiency.
*   **Capital and Profitability:** Equity is stable, and ROE (Return on Equity) is also showing signs of improvement. However, ROE values below 10% are less attractive, pointing towards slow equity growth.

**7. Comprehensive Analysis (Summary):**

*   **Underperformance:** CRM has significantly underperformed the S&P 500, with a large negative divergence. Recent positive movement but still needs to catch up.
*   **Volatility:** CRM exhibits higher volatility than the overall market, with a consistently high Beta and significant Maximum Drawdown.
*   **Mixed Signals:** Technical indicators present a mixed picture. The MRI suggests a moderate investment, while the RSI is neutral. The expected return is concerning, indicating no anticipated outperformance.
*   **Positive Earnings:** Recent earnings data shows solid growth in both EPS and revenue, and high profit margins.
*   **Analyst Optimism:**  Analyst consensus is "Buy" with a significant upside potential based on target prices, but the range is wide.
*   **Recent News:** News sentiment has been relatively positive, with signs of a potential price recovery and new partnerships.
* **Share Buyback and Dividend Policies:** Please be aware that CRM currently does not provide any dividend to their stockholders. Instead, they are focusing on Stock Repurchase Program (buyback) which is beneficial for the company (reduce the total outstanding shares; the EPS increase). However, this is a point of concern for investment decision (the company may have other investment option; not returning cash to the investors).

**Conclusion:**

While CRM has faced challenges and underperformed the market in the recent past, there are signs of potential recovery. The solid earnings growth, analyst optimism, and recent news sentiment point towards a possible turnaround. However, the high volatility, lack of expected outperformance, and high MDD remain significant concerns. Investors should weigh these factors carefully before making an investment decision.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.